EGFR and glioblastoma: In GBM, constitutively activated EGFR/SRC/ERK pathway results in YTHDF2 overexpression and subsequently downregulate LXRA and HIVEP2 expression, thereby disrupting cholesterol homeostasis and sustaining GBM tumorigenesis.417